Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
March 21, 2024
Western Blot of Tau Protein from Mouse Brains Extracts: How to Avoid Signal Artifacts
Parissa Fereydouni-Forouzandeh, Geoffrey Canet, Sofia Diego-Diàz, et al.
Neurobiology of Aging
|
March 25, 2022
Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia
Isabelle Guisle, Geoffrey Canet, Séréna Pétry, et al.
Frontiers in Cellular Neuroscience
|
September 27, 2018
HIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?
Geoffrey Canet, Chloé Dias, Audrey Gabelle, et al.
Frontiers in Neuroscience
|
August 22, 2024
Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington's disease
Behnaz Nateghi, Remi Keraudren, Gabriel Boulay, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 10, 2020
Glucocorticoid receptors signaling impairment potentiates amyloid-β oligomers-induced pathology in an acute model of Alzheimer's disease
Geoffrey Canet, Fanny Pineau, Charleine Zussy, et al.
Experimental Neurobiology
|
January 10, 2024
Temperature-induced Artifacts in Tau Phosphorylation: Implications for Reliable Alzheimer's Disease Research
Geoffrey Canet, Emma Rocaboy, Francis Laliberté, et al.
British Journal of Pharmacology
|
January 31, 2025
Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models
Geoffrey Canet, Charleine Zussy, Mathieu Vitalis, et al.
Oncotarget
|
May 8, 2018
Deletion of plasma <i>Phospholipid Transfer Protein (PLTP)</i> increases microglial phagocytosis and reduces cerebral amyloid-β deposition in the J20 mouse model of Alzheimer's disease
Marine Mansuy, Stella Baille, Geoffrey Canet, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 17, 2019
The GR-ANXA1 pathway is a pathological player and a candidate target in epilepsy
Emma Zub, Geoffrey Canet, Rita Garbelli, et al.
Epilepsia
|
February 28, 2022
Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways
Geoffrey Canet, Emma Zub, Charleine Zussy, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Methods in Molecular Biology (Clifton, N.J.)
|
March 21, 2024
Western Blot of Tau Protein from Mouse Brains Extracts: How to Avoid Signal Artifacts
Parissa Fereydouni-Forouzandeh, Geoffrey Canet, Sofia Diego-Diàz, et al.
Neurobiology of Aging
|
March 25, 2022
Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia
Isabelle Guisle, Geoffrey Canet, Séréna Pétry, et al.
Frontiers in Cellular Neuroscience
|
September 27, 2018
HIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?
Geoffrey Canet, Chloé Dias, Audrey Gabelle, et al.
Frontiers in Neuroscience
|
August 22, 2024
Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington's disease
Behnaz Nateghi, Remi Keraudren, Gabriel Boulay, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 10, 2020
Glucocorticoid receptors signaling impairment potentiates amyloid-β oligomers-induced pathology in an acute model of Alzheimer's disease
Geoffrey Canet, Fanny Pineau, Charleine Zussy, et al.
Experimental Neurobiology
|
January 10, 2024
Temperature-induced Artifacts in Tau Phosphorylation: Implications for Reliable Alzheimer's Disease Research
Geoffrey Canet, Emma Rocaboy, Francis Laliberté, et al.
British Journal of Pharmacology
|
January 31, 2025
Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models
Geoffrey Canet, Charleine Zussy, Mathieu Vitalis, et al.
Oncotarget
|
May 8, 2018
Deletion of plasma <i>Phospholipid Transfer Protein (PLTP)</i> increases microglial phagocytosis and reduces cerebral amyloid-β deposition in the J20 mouse model of Alzheimer's disease
Marine Mansuy, Stella Baille, Geoffrey Canet, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 17, 2019
The GR-ANXA1 pathway is a pathological player and a candidate target in epilepsy
Emma Zub, Geoffrey Canet, Rita Garbelli, et al.
Epilepsia
|
February 28, 2022
Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways
Geoffrey Canet, Emma Zub, Charleine Zussy, et al.
Page
of 3